Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-05

FDA Approved: CILOXAN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Ciloxan (ciprofloxacin hydrochloride) submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CILOXAN (Ciprofloxacin hydrochloride)

Snippet

SUPPL AP for CILOXAN (CIPROFLOXACIN HYDROCHLORIDE)